Indeed, more recent work has demonstrated that NAIP-NLRC4 inflammasome activation in gut epithelial cells is sufficient to protect mice from infection by Shigella flexneri, an important gastrointestinal pathogen of humans (Suzuki et al. 2014, Mitchell et al. 2020). The gene discussed is NLRC4; the disease is infection.